top of page
  • Writer's pictureJatin Agarwal

GPT Healthcare IPO

GPT Healthcare IPO: Revolutionizing Eastern India's Healthcare Sector


GPT Healthcare LOGO

Company Overview

GPT Healthcare, established in 2000 by Dr. Om Tantia, operates as a leading healthcare provider in Eastern India. With four multispecialty hospitals encompassing 561 beds, it focuses on secondary and tertiary care, offering services across a wide range of specialties from cardiology to neonatology. The company's significant growth, with a CAGR of 53.87% from FY2021-23, underscores its commitment to quality and affordability, especially in underserved markets​

​.

Company Financials

GPT Healthcare's financials indicate a positive trajectory with its revenue for the period ending September 30, 2023, reaching ₹206.70 Crores and a profit after tax (PAT) of ₹23.49 Crores. The company has shown consistent growth in net sales, operating profit, and net profit over the years, reflecting its operational efficiency and market acceptance​

​.

IPO Details

  • IPO Opening Date: February 22, 2024

  • IPO Closing Date: February 26, 2024

  • Price Band: ₹177 to ₹186 per share

  • Issue Size: ₹525.14 Crores, combining a fresh issue and an offer for sale​

  • Minimum Lot Size: 80 Shares

  • Minimum Investment: ₹14,880 for retail investors

​​

Objectives of the Issue

The IPO aims to raise capital to further enhance its healthcare facilities, support expansion plans, and improve its services across Eastern India, thereby contributing significantly to the region's healthcare infrastructure​

SWOT Analysis of GPT Healthcare IPO


Strengths

  • Strong Regional Presence: GPT Healthcare operates four multispecialty hospitals with 561 beds in Eastern India, indicating a significant footprint in the region.

  • Wide Range of Specialties: The company offers services across various specialties from cardiology to neonatology, catering to diverse healthcare needs.

  • Growth Trajectory: Exhibiting a CAGR of 53.87% from FY2021-23, GPT Healthcare showcases strong growth potential and operational success​.

Weaknesses

  • Geographic Concentration: Focused primarily in Eastern India, GPT Healthcare's operations might be vulnerable to regional economic fluctuations and local competition.

  • Dependence on Insurance Networks: As with many healthcare providers, there may be a reliance on insurance networks for patient referrals, which could impact service pricing and accessibility.

Opportunities

  • Expansion Potential: There's ample opportunity for GPT Healthcare to expand its services to other parts of India, addressing the healthcare needs of a larger population.

  • Technological Integration: Investing in telemedicine and digital health platforms could enhance patient care and operational efficiency, tapping into the growing trend of online healthcare services.

Threats

  • Increasing Competition: The healthcare sector in India is becoming increasingly competitive, with new players entering the market and existing ones expanding their services.

  • Regulatory Changes: Healthcare providers are subject to stringent regulatory requirements, and any changes in healthcare laws or insurance policies could impact operations and profitability.


Key Performance Indicators

  • ROE: 23.59%

  • ROCE: 26.09%

  • Debt/Equity: 0.39

  • RoNW: 23.77%

  • P/BV: 9.06 The company's strong KPIs reflect its robust financial health and operational efficiency, positioning it well for future growth​.


IPO Grey Market Premium (GMP) of GPT Healthcare

As of today, the GPT Healthcare IPO Grey Market Premium (GMP) is NIL.


Conclusion

GPT Healthcare's IPO represents a significant opportunity for investors to engage with a healthcare provider that has a profound impact on Eastern India's healthcare landscape. With its strong financials, extensive healthcare services, and strategic growth initiatives, GPT Healthcare is poised for further success.


Disclaimer

All information is provided for educational and informational purposes only. Data is fetched from publicly available sources such as the DRHP filed by the company and other reliable sources. The website or the author takes no guarantee for the accuracy of the data; however, we have tried our best to present accurate data to our readers. Please consult a financial advisor or do your own analysis before investing/trading in the stock market.

50 views0 comments

Recent Posts

See All

Comments


bottom of page